Big difference it could be that Keytruda has very severe , and sometimes deadly side effects , and efficacy is still not super high ..

So let’s see what results we will have with few more patients and let’s see what FDA will do with Leronlimab ..

I never saw in my medical life , drug helping deadly diseases without one severe side effect , so we will see what will happen here ..,

And BTW it is acceptable if different people have different expectation , plus we all know that expectation don’t always coming at this time, and delays do happen often ..



All imo ..